CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Imatinib Mesylate can induce complete molecular remission in FIP1L1-PDGFR-alpha positive idiopatic hypereosinophilic sindrome.
Authors
Baccarani M.
Cilloni D
+9 more
Gitani S
Malagola M
Martinelli G
Ottavini E
Piccaluga PP
Rondoni M
Rosti G
Saglio G
Trabacchi E
Publication date
1 January 2003
Publisher
'American Society of Hematology'
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Archivio istituzionale della ricerca - Università di Brescia
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:iris.unibs.it:11379/155583
Last time updated on 12/11/2016